PolicyLatest
FDA Supports Domestic Drug Production and Gilead Deal Insights
The FDA is backing the domestic production of pharmaceuticals, aiming to enhance supply chain resilience. Additionally, there are updates on a new deal involving Gilead, highlighting ongoing developments in the pharmaceutical sector.
0 upvotes
What happened
The FDA is backing the domestic production of pharmaceuticals, aiming to enhance supply chain resilience.
Why it matters
Additionally, there are updates on a new deal involving Gilead, highlighting ongoing developments in the pharmaceutical sector.